SMAD4 and neoplasm: A recent study provided evidence indicating that tranilast inhibited TGF-β1-induced epithelial–mesenchymal transition (EMT), tumor invasiveness, and metastasis by suppressing Smad4 expression in human non-small cell lung cancer [14].